Ex-RBS head says it is timely to allow new person to oversee deal
BENGALURU: GlaxoSmithKline Plc (GSK) chairman Philip Hampton will step down after more than 3½ years in the role, as Britain’s biggest drugmaker prepares to split its business into two.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!